Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Unmet Need – Unmet Need – Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Leukemia (US/EU)
Chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL) is a type of B-cell non-Hodgkin’s lymphoma and represents the most common form of leukemia in adults. The R/R CLL treatment…
Post-Traumatic Stress Disorder – Executive Insights – Executive Insights – Post-Traumatic Stress Disorder (US)
Post-traumatic stress disorder (PTSD) is a chronic psychiatric condition that may emerge after a person experiences a traumatic event or series of events. Multiple guidelines recommend first…
Dry and Wet Age-Related Macular Degeneration – Access & Reimbursement – Access & Reimbursement – Age-Related Macular Degeneration (US)
The age-related macular degeneration (AMD) therapy market in the United States is unique because the market penetration of approved branded therapies—Roche / Genentech’s Lucentis, Regeneron’s…
Sickle Cell Disease – Access & Reimbursement – Access & Reimbursement – Sickle Cell Disease (US)
Sickle cell disease (SCD) is a rare genetic blood disorder characterized by polymerization of hemoglobin in red blood cells that distorts them into a sickle shape, leading to various complications…
Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS-Constipation (Including IBS Without Diarrhea) | US | 2024
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is classified into three subtypes:…
Bladder Cancer and Upper Tract Urothelial Carcinoma – Current Treatment – Treatment Sequencing – Bladder Cancer and Upper Tract Urothelial Carcinoma (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…